Form 8-K - Current report:
SEC Accession No. 0001171843-25-001900
Filing Date
2025-04-01
Accepted
2025-04-01 07:00:17
Documents
26
Period of Report
2025-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040125.htm   iXBRL 8-K 23417
2 PRESS RELEASE exh_991.htm EX-99.1 19146
3 EXHIBIT 99.2 exh_992.htm EX-99.2 14307
4 exh992_01.jpg GRAPHIC 190276
5 exh992_02.jpg GRAPHIC 214755
6 exh992_03.jpg GRAPHIC 150135
7 exh992_04.jpg GRAPHIC 145134
8 exh992_05.jpg GRAPHIC 195159
9 exh992_06.jpg GRAPHIC 105909
10 exh992_07.jpg GRAPHIC 154176
11 exh992_08.jpg GRAPHIC 165202
12 exh992_09.jpg GRAPHIC 166977
13 exh992_10.jpg GRAPHIC 122441
  Complete submission text file 0001171843-25-001900.txt   2488498

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
15 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
16 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
17 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
28 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040125_htm.xml XML 3424
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 25796537
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)